Merck: A Gem In A Period Of Economic And Geopolitical Uncertainties [Seeking Alpha]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Seeking Alpha
FatCameraIn the first half of 2022, Merck medicines (NYSE:MRKproduct portfolio, Merck's revenue and operating income show a significant increase of tens of percent compared to the previous year. With a high dividend yield of 3.21%, Merck is an attractive candidate for investors with a long-term investment strategy during a Fed rate-hiking cycle.Company's Financial PositionMerck pleased investors with revenue growth for the second quarter of 2022, which amounted to $14,593 million, up 28% year-over-year. At the same time, the 8.2% drop in sales of the pharmaceutical giant compared to the previous quarter was the result of a decrease in demand for Lagevrio, used to combat COVID-19, which is moving from a pandemic stage to an endemic one.Source: Author's elaboration, based on Seeking AlphaSales of Merck's oncology portfolio continue to show growth both quarterly and year-on-year, which is directly related to the expansion of indications for the use of medicines and increased demand for t
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck's (NYSE:MRK) investors will be pleased with their notable 90% return over the last three years [Yahoo! Finance]Yahoo! Finance
- Merck: The Worst Has Been Avoided (Rating Upgrade) [Seeking Alpha]Seeking Alpha
- Merck's trial of KEYTRUDA regimen fails to meet primary endpoint [Yahoo! Finance]Yahoo! Finance
- Billionaire-Backed Cancer Researcher Claire Mazumdar Finds Entrepreneurial Niche [Forbes]Forbes
- Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 4/25/24 - Beat
MRK
Sec Filings
- 5/6/24 - Form 144
- 5/6/24 - Form 4
- 5/6/24 - Form 4
- MRK's page on the SEC website